AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. (Q53638690)

16 May 2018

title

AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. (English)

1 reference

16 May 2018

0 references

Rashna Madan

1

1 reference

16 May 2018

Robert Gormley

2

1 reference

16 May 2018

Alina Dulau

3

1 reference

16 May 2018

Dongsheng Xu

4

1 reference

16 May 2018

Daniel Walsh

5

1 reference

16 May 2018

K H Ramesh

6

1 reference

16 May 2018

Linda Cannizaro

7

1 reference

16 May 2018

Ecaterina F Tamas

8

1 reference

16 May 2018

Pankaj Kumar

9

1 reference

16 May 2018

Joseph Sparano

10

1 reference

16 May 2018

Aaron LeValley

11

1 reference

16 May 2018

Xiaonan Xue

12

1 reference

16 May 2018

Pritish K Bhattacharyya

13

1 reference

16 May 2018

Harry L Ioachim

14

1 reference

16 May 2018

Howard Ratech

15

1 reference

16 May 2018

publication date

1 March 2006

1 reference

16 May 2018

published in

Modern Pathology

1 reference

16 May 2018

volume

19

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

438-446

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.3800493

exact match

0 references

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Gene expression patterns in AIDS versus non-AIDS-related diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Pathology of AIDS-related lymphomas and other AIDS-defining neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

7 January 2021

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

7 January 2021

Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800493

7 January 2021

10.1038/MODPATHOL.3800493

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018